Oxiracetam and piracetam, aniracetam is currently commonly used in clinical three kinds of metabolic improvement of drugs for the pyrrolidone derivatives, by the Italian company Skebiqim in 1974, successfully developed, listed in 1987 . The mechanism of action of oxiracetam is similar to that of piracetam, which can promote the synthesis of phosphorylcholine and phosphoryl ethanolamine, increase the ratio of ATP / ADP in the brain, increase the synthesis of protein and nucleic acid in the brain, and improve the senile dementia And memory impairment in patients with memory and learning function. In animal experiments, it can be found in a variety of behavioral experiments can improve memory function and learning performance, can reduce the brain electrical shock caused by memory impairment, antagonistic spontaneously hypertensive cerebrovascular injury in rats learning ability reduction, it can Increased acetylcholine in the cortex and hippocampus of the rat was enhanced in favor of choline uptake. For brain damage and caused by neurological deficits, memory and treatment of mental retardation.
China
